Search PubMed⌕ Search

PubMed · 7600725

Electrocoagulation diathermy.

Abstract

With experience extending over an interval of 25 years, one single application of electrocoagulation diathermy has been substantiated as a most consistent and effective method of eradicating precancerous lesions of the cervix. Although there is a protocol for selection that must be adhered to, the vast majority of patients with CIN lesions are suitable for this method of ablative therapy. Ablation by electrocoagulation diathermy appears to have distinct advantages over other methods because of the following: 1. Very high cure rates (98%) with first-time treatment can be achieved, even for major dysplasia and/or carcinoma in situ. 2. Extensive and deep lesions can be effectively eradicated irrespective of the purported histological severity. 3. Electrodiathermy is capable of eradicating lesions extending into the endocervical canal, providing anatomical limits can be evaluated colposcopically. 4. The technique is simple and rapid. The versatility of the electrodes facilitates eradication of the lesion irrespective of the shape and contour of the cervix. 5. No expensive capital outlay nor costly maintenance of equipment is required. 6. There are no physical hazards for medical personnel. 7. It is cost-effective--the technique is readily adaptable as a true out-patient procedure on a 'walk in, walk out' basis. 8. It has a very low incidence of surgical morbidity and does not jeopardize physiological and reproductive function. 9. For practical purposes, the subsequent risk of development of invasive cancer of the cervix can be effectively eliminated.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W Chanen. 1995. Electrocoagulation diathermy.. https://doi.org/10.1016/s0950-3552(05)80364-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Vaccinations in pregnancy.

Adult immunization rates have fallen short of national goals partly because of misconceptions about the safety and benefits of current vaccines. The danger of these misconceptions is magnified during pregnancy, when concerned physicians are hesitant to administer vaccines and patients are reluctant to accept them. Routine vaccines that generally are safe to administer during pregnancy include diphtheria, tetanus, influenza, and hepatitis B. Other vaccines, such as meningococcal and rabies, may be considered. Vaccines that are contraindicated, because of the theoretic risk of fetal transmission, include measles, mumps, and rubella; varicella; and bacille Calmette-Guerin. A number of other vaccines have not yet been adequately studied; therefore, theoretic risks of vaccination must be weighed against the risks of the disease to mother and fetus. Inadvertent administration of any of these vaccinations, however, is not considered an indication for termination of the pregnancy.

Contraindications↗